Jason Meyenburg

Chief Executive Officer at

Gemini Therapeutics Sub, Inc.

49 year

68 connections

Health Technology

Consumer Services

Technology Services

Profile

Jason Meyenburg currently works at Gemini Therapeutics Sub, Inc., as Chief Executive Officer & Director from 2019.
Mr. Meyenburg also formerly worked at Auregen Biotherapeutics SA, as Chief Executive Officer, Gemini Therapeutics, Inc., as President, Chief Executive Officer & Director, Alexion Pharmaceuticals, Inc., as Senior Vice President-Commercial Operations from 2003 to 2016, Sucampo Pharmaceuticals LLC, as Chief Commercial Officer from 2017 to 2018, Alexion Pharma GmbH, as Vice President-Commercial Operations from 2010 to 2014, Vtesse, Inc., as Chief Commercial Officer from 2016 to 2017, and Orchard Therapeutics Plc, as Chief Commercial Officer from 2018 to 2019.
Mr. Meyenburg received his undergraduate degree from the University of Maryland and Masters Business Admin degree from The Fuqua School of Business.

Jason Meyenburg active positions

Companies	Position	Start
Gemini Therapeutics Sub, Inc. Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases	Chief Executive Officer	2019-09-12

All active positions of Jason Meyenburg

Former positions of Jason Meyenburg

Companies	Position	End
GEMI THER	Chief Executive Officer	2022-02-27
ORCHARD THERAPEUTICS PLC	Corporate Officer/Principal	2019-09-12
SUCAMPO PHARMACEUTICALS, INC.	Corporate Officer/Principal	2018-02-28
Vtesse, Inc. Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases	Corporate Officer/Principal	2017-03-31
ALEXION PHARMACEUTICALS, INC.	Corporate Officer/Principal	2016-01-31

See the detail of Jason Meyenburg's experience

Training of Jason Meyenburg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jason Meyenburg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders	Health Technology
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sucampo Pharmaceuticals LLC Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products	Health Technology
Alexion Pharma GmbH Alexion Pharma GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders	Health Technology
The Fuqua School of Business The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vtesse, Inc. Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases	Health Technology
Gemini Therapeutics Sub, Inc. Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases	Health Technology
Auregen Biotherapeutics SA Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Develops bio therapeutics platform for three-dimensional bio printing technology	Technology Services
Orchard Therapeutics Plc Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases	Health Technology
Gemini Therapeutics, Inc. Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases	Health Technology